CALIXAR is a biotech company specialized in the isolation of native membrane therapeutic targets and antigens. This digital event will be the opportunity to present CALIXAR’s proprietary technologies and know-how to any partner who wants to contribute to generate drugs, antibodies or vaccines to fight infectious diseases.
The purpose of this two-day congress is to foster interactions between pharmaceutical industries, research labs, service providers, technology developers, and clinicians, thereby contributing to the development of innovative strategies against infectious diseases in a multidisciplinary approach. The I4ID2020 edition will largely address the current COVID-19 pandemics as well as other infectious diseases.
For more information: https://www.i4id.org/